- Home
- PLSE vs OPK Comparison
PLSE vs OPK Comparison
Compare PLSE & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- OPK
- Stock Information
- Founded
- PLSE 2014
- OPK 2007
- Country
- PLSE United States
- OPK United States
- Employees
- PLSE N/A
- OPK N/A
- Industry
- PLSE Medical/Dental Instruments
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- PLSE Health Care
- OPK Health Care
- Exchange
- PLSE Nasdaq
- OPK Nasdaq
- Market Cap
- PLSE 1.1B
- OPK 1.0B
- IPO Year
- PLSE 2016
- OPK 1995
- Fundamental
- Price
- PLSE $16.27
- OPK $1.39
- Analyst Decision
- PLSE Buy
- OPK Buy
- Analyst Count
- PLSE 1
- OPK 4
- Target Price
- PLSE $22.00
- OPK $2.75
- AVG Volume (30 Days)
- PLSE 178.1K
- OPK 2.0M
- Earning Date
- PLSE 10-29-2025
- OPK 11-06-2025
- Dividend Yield
- PLSE N/A
- OPK N/A
- EPS Growth
- PLSE N/A
- OPK N/A
- EPS
- PLSE N/A
- OPK N/A
- Revenue
- PLSE N/A
- OPK $664,029,000.00
- Revenue This Year
- PLSE N/A
- OPK N/A
- Revenue Next Year
- PLSE $700.00
- OPK $0.84
- P/E Ratio
- PLSE N/A
- OPK N/A
- Revenue Growth
- PLSE N/A
- OPK N/A
- 52 Week Low
- PLSE $13.77
- OPK $1.11
- 52 Week High
- PLSE $25.00
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- PLSE 56.35
- OPK 51.88
- Support Level
- PLSE $13.83
- OPK $1.34
- Resistance Level
- PLSE $16.80
- OPK $1.44
- Average True Range (ATR)
- PLSE 0.73
- OPK 0.04
- MACD
- PLSE 0.10
- OPK -0.00
- Stochastic Oscillator
- PLSE 82.15
- OPK 50.00
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.